Immunome
$24.069876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$24.06
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$2.24 (-8.52%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Immunome and other stocks, options, and ETFs commission-free!
About IMNM
Immunome, Inc. Common Stock, also called Immunome, is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products.
CEO
Purnanand D. Sarma
Employees
23
Headquarters
Exton, Pennsylvania
Founded
2006
Market Cap
289.72M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
73.04K
High Today
$26.01
Low Today
$23.16
Open Price
$26.01
Volume
165.60K
52 Week High
$63.78
52 Week Low
$9.28
IMNM Earnings
-$7.52
-$5.01
-$2.51
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours